Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 912,000 | 1,060,000 | 1,023,000 | 988,000 | 1,054,000 |
| Receivables | 175,000 | 192,000 | 201,000 | 214,000 | 226,000 |
| Inventories | 76,000 | 73,000 | 76,000 | 69,000 | 71,000 |
| Other current assets | 0 | 35,000 | 0 | 0 | 0 |
| TOTAL | $1,163,000 | $1,360,000 | $1,300,000 | $1,271,000 | $1,351,000 |
| Non-Current Assets | |||||
| PPE Net | 56,000 | 60,000 | 55,000 | 57,000 | 59,000 |
| Intangibles | 66,000 | 72,000 | 73,000 | 77,000 | 82,000 |
| Other Non-Current Assets | 227,000 | 160,000 | 162,000 | 163,000 | 113,000 |
| TOTAL | $349,000 | $292,000 | $290,000 | $297,000 | $254,000 |
| Total Assets | $1,512,000 | $1,652,000 | $1,590,000 | $1,568,000 | $1,605,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 |
| Accounts payable and accrued liabilities | 487,000 | 623,000 | 524,000 | 553,000 | 658,000 |
| Other current liabilities | 138,000 | 71,000 | 54,000 | 54,000 | 62,000 |
| TOTAL | $665,000 | $742,000 | $622,000 | $645,000 | $753,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 232,000 | 233,000 | 234,000 | 235,000 | 236,000 |
| Other Non-Current Liabilities | 576,000 | 468,000 | 482,000 | 483,000 | 483,000 |
| TOTAL | $808,000 | $701,000 | $716,000 | $718,000 | $719,000 |
| Total Liabilities | $1,473,000 | $1,443,000 | $1,338,000 | $1,363,000 | $1,472,000 |
| Shareholders' Equity | |||||
| Common Shares | 73,000 | 73,000 | 73,000 | 73,000 | 73,000 |
| Retained earnings | 1,288,000 | 1,449,000 | 1,506,000 | 1,453,000 | 1,376,000 |
| Other shareholders' equity | -1,328,000 | -1,318,000 | -1,332,000 | -1,326,000 | -1,321,000 |
| TOTAL | $39,000 | $209,000 | $252,000 | $205,000 | $133,000 |
| Total Liabilities And Equity | $1,512,000 | $1,652,000 | $1,590,000 | $1,568,000 | $1,605,000 |